Spencer Stumpf — Pfizer (United States)

Area of research

Infectious Diseases · Pharmacology

Research interest

Research interests include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Microbial Natural Products and Biosynthesis, and Genomics and Phylogenetic Studies.

h-index

citations

2,579

works

NIH funding

—

primary concept

Biology

✉ Find email ↗

Recent publications

Defining the risk of SARS-CoV-2 variants on immune protection

Nature 2022cited by 180position: middledoi

Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization

Cell Host & Microbe 2021cited by 847position: middledoi

SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape

Nature 2021cited by 582position: middledoi

In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains

Nature 2021cited by 260position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Infectious Diseases · Pharmacology →